Lifeboat Foundation

This is not that far fetch especially when we have seen DARPA’s efforts around BMI, the nanobot technology being experimented on to enable BMI, stent technology as well that is being looked at for BMI, etc. which all leads us into the concept of superhumans.

“Humans are so slow” says Elon Musk, so let’s become AI-human symbiotes instead.

Very true points that many have been raising with CRISPR, Synthetic Biology, BMI, and humanoid technology. I am glad to see this article on ethics and standards because it really needs to be discussed and implemented.

New brain technologies will increasingly have the potential to alter how someone thinks, feels, behaves and even perceives themselves.

By Nicholas West

Continue reading “Is it already too late to consider the ethics of mind control technology?” »

Sharing for all my Neuro science friends and techie friends — Sept 29th is the Inaugural Cornell Neurotech Mong Family Foundation Symposium. Some of Cornell’s top award winning neuro scientists will be presenting.

Interested in learning how the brain works?

Some of Cornell’s best scientists studying the brain will gather Sept. 29 for the Inaugural Cornell Neurotech Mong Family Foundation Symposium. The symposium features three alumni winners of the 2015 Brain Prize – Winfried Denk, Ph.D. ’89, Karel Svoboda ’88 and David Tank, M.S. ’80, Ph.D. ’83 – as well as award-winning Cornell faculty who will share how they are exploring the brain using the most modern, innovative technologies.

Talks begin at 10 a.m. in Room G10 Biotechnology and conclude at 5 p.m. with a public reception. The symposium is free and the public is invited.

Continue reading “Neurotech symposium features Brain Prize winners” »

Abstract: Fuel cells have long held promise as power sources, but low efficiency has created obstacles to realizing that promise. Researchers at the University of Illinois and collaborators have identified the active form of an iron-containing catalyst for the trickiest part of the process: reducing oxygen gas, which has two oxygen atoms, so that it can break apart and combine with ionized hydrogen to make water. The finding could help researchers refine better catalysts, making fuel cells a more energy- and cost-efficient option for powering vehicles and other applications.

Led by U. of I. chemistry professor Andrew Gewirth, the researchers published their work in the journal Nature Communications.

Iron-based catalysts for oxygen reduction are an abundant, inexpensive alternative to catalysts containing precious metals, which are expensive and can degrade. However, the process for making iron-containing catalysts yields a mixture of different compounds containing iron, nitrogen and carbon. Since the various compounds are difficult to separate, exactly which form or forms behave as the active catalyst has remained a mystery to researchers. This has made it difficult to refine or improve the catalyst.

Georgia Tech researchers have developed a new strategy for crafting one-dimensional cellulose nanorods using a wide range of precursor materials.

An international team have developed nanobots that travel in the bloodstream and tackle cancer from the inside.

Hmmm.

For the first time, Israeli researchers have developed a system that lets a human use brain waves to control nanobots in a cockroach. How could that help your health?

Nice highlight on 3 of the top medical technologies.

By now, you’ve no doubt heard of CRISPR, the latest gene-editing tool sweeping research labs across the globe. It was first discovered in certain strains of bacteria, who use it as an important weapon against dangerous viruses. In bacteria, CRISPR identifies a virus that poses a threat, records the virus’ genetic data and imprints it onto RNA molecules. An immune enzyme called Cas9 grabs one of the RNA molecules and goes exploring. When Cas9 encounters a virus that matches the data on the RNA molecule, it latches on and slices the virus in half to prevent it from replicating and posing any threat.

Researchers have co-opted the CRISPR/Cas9 mechanism to edit genes. Instead of copying dangerous viral DNA sequences onto the RNA molecules, they can copy over any sequence they want to edit. And instead of Cas9 destroying viruses, it makes precise cuts and removes specific bits of genetic data from the designated sequence. This allows researchers to target and edit specific gene sequences with genetic data of their choosing.